The FDA approved only 34 novel drugs in 2022 compared to 50 in 2021. The highest number of novel drug approvals was in 2018, which saw 59 novel drugs cross the finish line, and the second-best year was 1993, when 53 novel drugs were approved.
Biotech Stocks Facing FDA Decision In March 2023